MedPath

Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children

Not Applicable
Completed
Conditions
Sinusitis
Interventions
Drug: placebo
Registration Number
NCT00944515
Lead Sponsor
Mahidol University
Brief Summary

The purpose of this study is to evaluate efficacy of azithromycin prophylaxis in preventing recurrent acute sinusitis in children.

Detailed Description

A Prospective, Randomized, Double-blind, Placebo Controlled Trial of azithromycin in preventing recurrent acute sinusitis in children

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • children between the age of 5 years and 15 years with the diagnosis of recurrent acute sinusitis who are attending the outpatient pediatric department, pediatric allergy clinic, and the ear, nose, throat clinic.
Exclusion Criteria
  • patients who have allergic rhinitis, chronic sinusitis, a history of allergic reactions to azithromycin or macrolides, treatments with immunotherapy or IVIG or gentamycin solution or pneumococcal vaccine during study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboplaceboplacebo 3 days/week
azithromycinazithromycinazithrimycin 3 days/week
Primary Outcome Measures
NameTimeMethod
frequence of acute sinusitis during 12 mouths of study period12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath